Amgen Inc. vs Johnson & Johnson — Stock Comparison
Amgen Inc. (AMGN) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Amgen Inc. narrowly edges Johnson & Johnson on Q·Score (7.1 vs 7 out of 10), led by Growth (8.9 vs 5) and Valuation (6.8 vs 6.5). Johnson & Johnson scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for JNJ (+4.6%) than for AMGN (+2.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 91% return on equity and 23% profit margins.
⚠ high leverage at 4.9× debt-to-equity.
High-quality business with 26% return on equity and 21% profit margins.
⚠ earnings contracting 1% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
AMGN vs JNJ: which stock scores better overall?
Based on Q·Score, Amgen Inc. (AMGN) scores 7.1/10 versus Johnson & Johnson (JNJ) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: AMGN or JNJ?
Amgen Inc. (AMGN) scores higher on Growth (8.9/10 vs 5/10). Amgen Inc. reports revenue growth (9.5% YoY) while Johnson & Johnson reports (6.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is AMGN or JNJ more attractively valued?
Amgen Inc. (AMGN) scores higher on Valuation (6.8/10 vs 6.5/10). AMGN trades at 15.5× P/E versus JNJ at 21.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about AMGN vs JNJ?
There are 29 analysts covering AMGN with a consensus price target of $388.03, and 22 analysts covering JNJ with a consensus target of $277.91. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: AMGN or JNJ?
Amgen Inc. (AMGN) scores higher on Quality (9.3/10 vs 9.3/10). Net profit margin: AMGN at 23.0%, JNJ at 21.5%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: AMGN or JNJ?
Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 4.5/10). Market beta: AMGN at 0.43, JNJ at 0.23. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of AMGN and JNJ?
Amgen Inc. (AMGN) has a market capitalisation of $204.0B, while Johnson & Johnson (JNJ) has a market cap of $640.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do AMGN or JNJ pay dividends?
AMGN pays a dividend yield of 2.64%, while JNJ pays a dividend yield of 2.02%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →